Recruiting Mesothelioma Studies in Commack
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
The purpose of this study is to find out whether intraperitoneal or intravenous chemotherapy given after cytoreductive surgery and HIPEC are effective treatments for people with malignant peritoneal m...
A Study of Sacituzumab Govitecan in People With Mesothelioma
Participants will receive sacituzumab govitecan until their disease gets worse (progresses), they have severe side effects and cannot continue study treatment, or the participants or the study doctor ...
About Mesothelioma Clinical Trials in Commack
Mesothelioma is a rare cancer that develops in the thin tissue lining the lungs, abdomen, or heart, primarily caused by asbestos exposure. Most cases are pleural mesothelioma affecting the lung lining. Treatment includes surgery, chemotherapy, radiation, and immunotherapy.
There are currently 2 mesothelioma clinical trials recruiting participants in Commack, NEW%20YORK. These studies are seeking a combined 97 participants. Research is being sponsored by Memorial Sloan Kettering Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.
Mesothelioma Clinical Trials in Commack — FAQ
Are there mesothelioma clinical trials in Commack?
Yes, there are 2 mesothelioma clinical trials currently recruiting in Commack, NEW%20YORK. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Commack?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Commack research site will contact you about next steps.
Are clinical trials in Commack free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Commack studies also compensate for your time and travel.
What mesothelioma treatments are being tested?
The 2 active trials in Commack are testing new therapies including novel drugs, biologics, and treatment approaches for mesothelioma.
Data updated March 2, 2026 from ClinicalTrials.gov